Blood Pressure Monitoring Devices Market

The blood pressure monitoring devices market is anticipated to expand from US$ 2.91 billion in 2024 to US$ 5.90 billion by 2031, with an estimated CAGR of 10.6% from 2025 to 2031.

Market Insights and Analyst Perspective:Blood pressure monitoring devices are essential for identifying hypertension in patients. High blood pressure is a significant risk factor for strokes and chronic heart diseases, which are leading causes of mortality globally. Recently, there has been a notable increase in the adoption of blood pressure monitoring devices in home care environments. Additionally, factors such as an aging population, lifestyle changes, and technological innovations are key contributors to the growth of the blood pressure monitoring devices market. These devices enable early detection of health deterioration in patients. Furthermore, advanced personal blood pressure monitors allow for remote health tracking.

Growth Catalysts:Rising Incidence of Cardiovascular Diseases Fuels Growth in Blood Pressure Monitoring Devices Market

Over the past decade, significant advancements in blood pressure monitoring devices have provided patients and healthcare providers with innovative ways to manage various conditions, including ventricular and atrial arrhythmias, as well as ventricular atrial fibrillation. The increasing prevalence of cardiovascular diseases (CVDs) such as sudden cardiac arrest, coronary heart disease, congenital heart defects, pulmonary hypertension, heart failure, and elevated pulmonary artery pressure (PA) supports the development of enhanced monitoring techniques. The ease of use and rapid detection of irregularities are critical advantages of blood pressure monitoring devices. According to the World Health Organization (WHO), approximately 30 million individuals experience strokes annually. The American Heart Association projects that over 130 million people in the US will have some form of CVD by 2035.

The European Society of Cardiology reports that atrial fibrillation is the most prevalent arrhythmia, accounting for 0.28% to 2.6% of healthcare expenditures in Europe. It also indicates that patients with atrial fibrillation face a fivefold increased risk of stroke, with 20% to 30% of all stroke cases in Europe attributed to this condition. A 2016 study by the European Society of Cardiology found that around 7.6 million individuals aged 65 and older in the EU had atrial fibrillation, with projections suggesting this number could rise by 89% to approximately 14.4 million by 2060. The prevalence of atrial fibrillation is expected to increase from 7.8% in 2016 to 9.5% by 2060. According to a 2019 report by Biosense Webster titled "The Impact of Atrial Fibrillation in Asia Pacific," around 16 million people in the Asia Pacific region suffer from atrial fibrillation, with estimates suggesting this could rise to nearly 72 million by 2050. The report highlights that middle-aged and elderly populations are at a higher risk of developing this condition.

Strategic Insights

Report Segmentation and Scope:The "Blood Pressure Monitoring Devices Market" is categorized based on product, type, and end users. In terms of product, the market includes mercury columns, aneroid blood pressure monitors, and digital blood pressure monitors. By type, the market is divided into arm, wrist, finger, and others. For end users, the market is segmented into hospitals and clinics, home care settings, ambulatory surgical centers, and others.

Segmental Analysis:In terms of product, the blood pressure monitoring devices market is divided into mercury columns, aneroid blood pressure monitors, and digital blood pressure monitors. In 2022, the digital blood pressure segment captured a significant market share and is projected to exhibit the fastest CAGR from 2022 to 2030. Digital blood pressure devices are designed for precision and accuracy in measuring blood pressure and pulse. They are generally easier to operate than aneroid monitors, featuring a stethoscope and gauge in one unit, along with an error indicator. The blood pressure readings are displayed on a small screen, making them easier to read than traditional dials. Digital monitors are particularly beneficial for hearing-impaired patients, as they do not require listening to heartbeats through a stethoscope.

By type, the blood pressure monitoring devices market is categorized into arm, wrist, finger, and others. In 2022, the arm segment held the largest market share and is expected to grow at the fastest CAGR from 2022 to 2030. Finger-based blood pressure monitoring technology operates similarly to pulse oximetry, utilizing light that reflects off the user's finger to assess blood flow through a photoplethysmogram (PPG) interpreted by various algorithms. In May 2023, engineers at the University of California San Diego introduced a low-cost clip that uses a smartphone's camera and flash to measure blood pressure at the fingertip. This device, which works with a custom app, currently costs about 80 cents to produce, with potential costs dropping to 10 cents per unit at scale. This innovation aims to simplify and make regular blood pressure monitoring affordable and accessible, particularly for older adults and pregnant women managing hypertension.

Regarding end users, the blood pressure monitoring devices market is segmented into hospitals and clinics, home care settings, ambulatory surgical centers, and others. In 2022, the hospitals and clinics segment held a substantial market share, while the home care settings segment is projected to experience the fastest CAGR from 2022 to 2030. Hospitals and clinics serve as the primary healthcare providers in many regions. The American Heart Association, Inc. reports that the prevalence of rhythm abnormalities among middle-aged and older adults is significant. Conditions such as atrial fibrillation, bradyarrhythmia, and conduction system diseases represent the majority of abnormal rhythm cases. For instance, cardiac arrhythmias affect at least 2.3 million individuals in the US, increasing the risk of stroke and mortality. Additionally, 90,000 cases of supraventricular tachycardia are diagnosed annually in the US, accounting for 25% of all emergency department visits for this condition. An NCBI report indicates that 2,020 (36.1%) out of 5,585 hospital admissions for cardiac arrhythmias involved concurrent arrhythmias. Thus, the growing number of multispecialty hospitals and the preference for hospitals and clinics over other healthcare facilities contribute to the expansion of the blood pressure monitoring devices market in this segment.

Regional Analysis:Geographically, the global blood pressure monitoring devices market is divided into Asia Pacific, Europe, Middle East & Africa, North America, and South & Central America. In 2022, North America held the largest share of the global blood pressure monitoring devices market, while Asia Pacific is expected to achieve the highest CAGR from 2022 to 2030.

The North American blood pressure monitoring devices market comprises the US, Canada, and Mexico. The market's growth in this region is driven by factors such as the rising incidence of cardiac diseases and ongoing research and development aimed at creating innovative sensor-based patient monitoring systems. Furthermore, many leading companies in the blood pressure monitoring devices sector are based in this region, facilitating market growth.

The US is the largest contributor to the blood pressure monitoring devices market both in North America and globally. Coronary heart disease is a leading cause of death in the US. As the largest economy in North America and the world, demographic trends in the US significantly influence the regional market, both positively and negatively. The increasing elderly population suggests a higher demand for patient monitoring equipment in the country.

Blood Pressure Monitoring Devices Market Report Scope

Industry Developments and Future Opportunities:Key initiatives by leading players in the blood pressure monitoring devices market include:

In January 2023, Valencell launched its own branded product line in the Digital Health sector, with its first product aimed at helping patients monitor and manage hypertension through an intuitive app paired with an innovative OTC device that accurately measures blood pressure from the finger without the need for a cuff or calibration.

In October 2022, OMRON Healthcare enhanced its blood pressure monitor portfolio by converting them into "connected" devices. This significant upgrade was designed to provide users and healthcare professionals with seamless, real-time, and accurate hypertension management. The connected devices enable effortless data transfer through the OMRON Connect application.

Competitive Landscape and Key Players:Prominent companies in the blood pressure monitoring devices market include Omron Healthcare, Welch Allyn, Inc., A&D Medical Inc., SunTech Medical, Inc., American Diagnostics Corp., Withings, GE Healthcare, Microlife AG, GF Health Products, Inc., Spacelabs Healthcare, and Baxter. These companies are focused on advancing technologies, enhancing existing products, and expanding geographically to meet the growing global consumer demand.